Nasdaq Approves Orchid s Bid to Secure $16M in Financing Without Shareholders Approval | GenomeWeb

NEW YORK, March 21 - Orchid BioSciences said yesterday that it had received a waiver from Nasdaq, allowing it to go ahead with a private financing of $16 million without seeking shareholders' approval.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.